LGVN Stock Analysis: Buy, Sell, or Hold?

LGVN - Longeveron Inc. Common Stock

PHARMACEUTICAL PREPARATIONS
$0.70
-0.05 (-6.94%) β–Ό
5d: -17.52%
30d: -37.27%
90d: +31.52%
WAIT
LOW Confidence
Analysis Updated: May 14, 2026 12:00 AM ET
Earnings: May 13, 2026 0d

Get Alerted When LGVN Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

πŸ’‘
Bottom Line:
⏸️ WAIT FOR STABILIZATION: LGVN is down 17.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
See Forward Earnings Fair Value & Price Prediction β†’

In-depth Analysis How we analyze

Valuation Analysis: LGVN is currently trading at $0.70, which is considered oversold relative to its 30-day fair value range of $0.83 to $1.10.

Technical Outlook: Technically, LGVN is in a strong uptrend. The price is currently testing key support at $0.71. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 6.9% recently.

Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $6.82 (+870.2%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position OVERSOLD
Historical Trading Range $0.83 - $1.10
Company Quality Score 45/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 77.4%

All Signals

  • BULLISH: Price oversold vs 30-day range
  • NEUTRAL: Mixed technical signals (40/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-6.9%)
  • BULLISH: Trading 870.2% below Wall St target ($6.82)
  • WARNING: Recommendation downgraded due to -17.5% 5-day decline - wait for stabilization

Trading Range Analysis

30-Day Trading Range $0.83 - $1.10
Current vs Trading Range OVERSOLD

Support & Resistance Levels

Support Level $0.71
Resistance Level $0.90
Current Trend Strong Uptrend
Technical data as of May 14, 2026

Fundamental Context

Forward P/E (Next Year Est.) -1.38
Wall Street Target $6.82 (+870.2%)
Revenue Growth (YoY) -39.5%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: May 15, 2026 7:34 AM ET
Data refreshes hourly during market hours. Next update: 8:34 AM
πŸ”₯ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for LGVN.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ALNY
Alnylam Pharmaceuticals …
STRONG BUY
33 analysts
$449 54 HOLD
SRPT
Sarepta Therapeutics Inc
STRONG BUY
26 analysts
$23 56 HOLD
CRSP
Crispr Therapeutics AG
BUY
28 analysts
$73 58 HOLD
DNLI
Denali Therapeutics Inc
STRONG BUY
19 analysts
$36 58 HOLD
INSM
Insmed Inc
STRONG BUY
19 analysts
$208 49 HOLD

More Analysis for LGVN

LGVN Technical Chart LGVN Price Prediction LGVN Earnings Date LGVN Investment Advisor LGVN Fair Price Analyzer LGVN Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals